Publications

• van Hellemond JJ, Molhoek N, Koelewijn R, Wismans PJ, van Genderen PJ. Is paromomycin the drug of choice for eradication of Blastocystis in adults? J Infect Chemother. 2013 Jun;19(3):545–8.
• Coyle CM, Varughese1 J, Weiss1 LM, and Tanowitz1 HB. Blastocystis: To Treat or Not to Treat... Clin Infect Dis. 2011;54 (1): 105-110.
• Stensvold CR, Smith HV, Nagel R, Olsen KE, Traub RJ. Eradication of Blastocystis carriage with antimicrobials: reality or delusion? J Clin Gastroenterol 2010;44:85-90.
• Stensvold CR, Nielsen HV, Mølbak K, Smith HV. Pursuing the clinical significance of Blastocystis – diagnostic limitations. Trends Parasitol. 2009;Jan. 25 (1):23-9.
• Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008:639-65.
• Yakoob J, Jafri W, Jafri N, Islam M, Asim Beg M. In vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome. Br J Biomed Sci 2004;61:75-7.
• Rossingnol JF, Kabil SM, Said M, Samir H, Younis AM. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol. 2005 Oct;3(10):987-91.
• Diaz E, Mondragon J, Ramirez E, Bernal R. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg 2003;68:384-5.
• Nigro L, Larocca L, Massarelli L, Patamia I, Minniti S, Palermo F, Cacopardo B. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 2003;10:128-30.

Back to Top